SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Topps Group’s arm launches Alusid floor tile range

24 May 2024 07:00

RNS Number : 7394P
Frontier IP Group plc
24 May 2024
 

Reach - a non-regulatory announcement

AIM: FIPP

24 May 2024

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Topps Group's Parkside arm launches Alusid floor tile range

 

 

Frontier IP, a specialist in commercialising intellectual property, today announces that portfolio company Alusid Limited ("Alusid" or the "Company") has launched its first range of floor tiles through Parkside Architectural Tiles ("Parkside"), the commercial arm of Topps Tiles Plc ("Topps Group" or "Topps").

 

Called Mas, the range is made from between 95 per cent and 98.5 per cent recycled content, depending on the colour, and has one of the lowest carbon footprint of tiles in the market*. This is an important consideration for a construction industry and its customers facing carbon taxes and tougher environmental regulations, and having to meet their own sustainability targets. Topps is expected to launch the range to retail customers later this year.

 

Floor tiles represent about 60 per cent of the total tile market. Mas tiles have been extensively tested, are hardwearing and have porcelain grade breaking strength. They are mass manufactured on industry-standard equipment, and production is sub-contracted.

 

Earlier this month, the Alusid-made Principle range, launched into the Topps retail chain last year, was named Wall Tile of The Year by The Tile Association at its annual awards.

 

Alusid raised £1.13 million from new and existing investors in January 2024, including a £500,000 investment from Octopus Investments through its Octopus AIM VCT 1 plc and Octopus AIM VCT 2 plc funds. The Company is now progressing with plans for an initial public offering later this year.

 

Other Alusid customers include Starbucks EMEA, H&M, Pret a Manger and the BBC. The Company is in discussions with potential distributors in Northern Europe to expand into new territories.

 

 

 

Topps Group Buying Director Tim Tatlock said: "Mas achieves market leading levels of innovation in recycled content floor tiles and has been enabled by the Alusid and Topps Group partnership. We are on a journey to place more sustainable tiling products into the market, something we are incredibly excited about as part of The Topps Group's strategic commitment to Environmental Leadership in our sector."

 

Alasdair Bremner, Alusid's CEO, said: "Launching Mas is a major milestone for Alusid and is the result of nearly two years of hard work from our R&D team in the UK and our production partners in Spain, we are proud to be bringing this range to the market and to have achieved such a considerable reduction in the carbon footprint of our first floor tile."

 

Frontier IP Chief Executive Neil Crabb said: "We are delighted that Alusid has successfully developed and launched its first range of floor tiles, which form a major part of the overall tile market. This is a big step forward for the Company and is sure to strengthen its appeal to investors as it explores an initial public offering."

 

*Mas carbon footprint is 5.90kg per m2 and is 45% lower carbon compared to the average Spanish tile as established by the Spanish Tile Manufacturers Association EPD. Alusid's carbon footprint was established by the Materials Processing Institute who independently conducted a Life Cycle Analysis on Alusid's dry granulation process. The Environmental Product Declaration (EPD) produced is currently proceeding through verification and is expected to be published by July 2024.

 

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

T: 0203 328 5656

 

 

 

ABOUT ALUSID

Alusid creates beautiful, premium-quality tiles and architectural surfaces by recycling industrial waste ceramics, glass and other materials much of which would otherwise end in landfill.

 

The company's Sustainable Tile ranges are distributed in the UK by Topps Tiles and Parkside Architectural Tiles. Sequel Vibe was named Wall Tile of The Year in The Tile Association's prestigious awards in 2020.

 

Alusid also makes its own surface products under the brand name SilicaStone distributed in the UK by Panaz. Customers include COS, part of H&M, Christian Dior, Nando's, Harrods, Selfridges, Amazon UK and Pret-a-Manger.

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGZKVFVGDZM
Date   Source Headline
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSUnaudited Half Year Results
24th Mar 20257:00 amRNSCamGraphIC secures €25 million in Series A funding
18th Mar 20257:00 amRNS-RPulsiv wins PSMA’s Global Energy Efficiency Award
25th Feb 20257:00 amRNS-RGraphEnergyTech collaboration & Innovate UK grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.